MARKET

LIVN

LIVN

Livanova Plc
NASDAQ
55.87
+1.48
+2.72%
After Hours: 55.87 0 0.00% 16:02 03/27 EDT
OPEN
54.69
PREV CLOSE
54.39
HIGH
56.32
LOW
54.63
VOLUME
416.46K
TURNOVER
0
52 WEEK HIGH
59.86
52 WEEK LOW
41.84
MARKET CAP
3.01B
P/E (TTM)
172.60
1D
5D
1M
3M
1Y
5Y
LivaNova Is Maintained at Buy by Mizuho
Dow Jones · 1d ago
LivaNova Price Target Maintained With a $75.00/Share by Mizuho
Dow Jones · 1d ago
Weekly Report: what happened at LIVN last week (0318-0322)?
Weekly Report · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: LivaNova (LIVN), Vor Biopharma (VOR) and Neurogene (NGNE)
TipRanks · 03/21 09:21
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
NASDAQ · 03/21 08:46
BUZZ-U.S. STOCKS ON THE MOVE-Enservco, Citigroup, Tencent
Wall Street's main stock indexes were little changed on Wednesday. The Dow Jones Industrial Average was down 0.02% at 39,103.12. The Federal Reserve is expected to keep interest rates unchanged at its meeting. Enservco, Citigroup, Tencent and Chevron rise.
Reuters · 03/20 17:45
LivaNova Price Target Maintained With a $72.00/Share by Needham
Dow Jones · 03/20 16:24
BUZZ-U.S. STOCKS ON THE MOVE-J.Jill, LivaNova, International Paper
Wall Street's main stock indexes were little changed on Wednesday. The Dow Jones Industrial Average was up 0.02% at 39,118.45. Chipotle Mexican Grill and American Airlines Group were among the top gainers. The Federal Reserve is expected to keep interest rates unchanged at its meeting.
Reuters · 03/20 16:20
More
About LIVN
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Webull offers LivaNova PLC stock information, including NASDAQ: LIVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LIVN stock methods without spending real money on the virtual paper trading platform.